CA
Cullinan Associates Portfolio holdings
AUM
$1.52B
This Quarter Return
+7.45%
1 Year Return
+25.73%
3 Year Return
+90.76%
5 Year Return
+138.02%
10 Year Return
+330.79%
AUM
$945M
AUM Growth
+$945M
(+7.6%)
Cap. Flow
+$7.34M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
68.38%
Holding
92
New
2
Increased
34
Reduced
45
Closed
4
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$19.1M |
| 2 |
Colgate-Palmolive
CL
|
$2.92M |
| 3 |
Kellanova
K
|
$2.27M |
| 4 |
Baxter International
BAX
|
$1.51M |
| 5 |
Amgen
AMGN
|
$1.4M |
Top Sells
| 1 |
Coca-Cola
KO
|
$4.24M |
| 2 |
Oracle
ORCL
|
$2.77M |
| 3 |
PepsiCo
PEP
|
$2.24M |
| 4 |
Schlumberger
SLB
|
$1.99M |
| 5 |
Clorox
CLX
|
$1.92M |
Sector Composition
| 1 | Consumer Staples | 46.52% |
| 2 | Healthcare | 18.92% |
| 3 | Energy | 9.17% |
| 4 | Industrials | 5.89% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Kellanova
K
$27.5B
| $2.27M | 0.24% |
+34,650
| New | +$2.27M |
|
|
PX
52
DELISTED
Praxair Inc
PX
| $2.17M | 0.23% |
16,780
-1,000
| -6% | -$130K |
|
53
Adobe
ADBE
$148B
| $2.17M | 0.23% |
29,800
+6,600
| +28% | +$480K |
|
54
Eli Lilly
LLY
$661B
| $2.16M | 0.23% |
31,300
-1,900
| -6% | -$131K |
|
55
BP
BP
$88.8B
| $2.14M | 0.23% |
56,060
-1,894
| -3% | -$104K |
|
56
Diageo
DEO
$61.1B
| $2.12M | 0.22% |
18,606
-3,250
| -15% | -$371K |
|
|
57
Oracle
ORCL
$628B
| $2.08M | 0.22% |
46,330
-61,570
| -57% | -$2.77M |
|
58
Altria Group
MO
$112B
| $2M | 0.21% |
40,655
-21,925
| -35% | -$1.08M |
|
59
CSX Corp
CSX
$60.2B
| $1.7M | 0.18% |
46,859
-17,300
| -27% | -$627K |
|
|
DD
60
DELISTED
Du Pont De Nemours E I
DD
| $1.66M | 0.18% |
22,465
-2,700
| -11% | -$200K |
|
61
Fifth Third Bancorp
FITB
$30.2B
| $1.65M | 0.17% |
80,840
| – | – |
|
|
XLNX
62
DELISTED
Xilinx Inc
XLNX
| $1.56M | 0.17% |
36,150
+1,800
| +5% | +$77.9K |
|
63
Devon Energy
DVN
$22.3B
| $1.56M | 0.16% |
25,460
-2,480
| -9% | -$152K |
|
|
GAP
64
The Gap, Inc.
GAP
$8.38B
| $1.54M | 0.16% |
36,505
+24,875
| +214% | +$1.05M |
|
65
Cigna
CI
$80.2B
| $1.52M | 0.16% |
14,740
-960
| -6% | -$98.7K |
|
66
Fiserv
FI
$74.3B
| $1.46M | 0.15% |
20,540
+8,540
| +71% | +$606K |
|
67
Norfolk Southern
NSC
$62.4B
| $1.45M | 0.15% |
13,207
-3,100
| -19% | -$340K |
|
|
STJ
68
DELISTED
St Jude Medical
STJ
| $1.44M | 0.15% |
22,100
+6,500
| +42% | +$423K |
|
69
Chubb
CB
$111B
| $1.41M | 0.15% |
12,300
-1,600
| -12% | -$184K |
|
|
MSS
70
DELISTED
MILESTONE SCIENTIFIC INC (NEW)
MSS
| $1.31M | 0.14% |
33,780
+1,000
| +3% | +$38.8K |
|
71
Allstate
ALL
$53.9B
| $1.2M | 0.13% |
17,026
-400
| -2% | -$28.1K |
|
72
Marsh & McLennan
MMC
$101B
| $1.14M | 0.12% |
20,000
| – | – |
|
73
Bank of America
BAC
$371B
| $1.1M | 0.12% |
61,350
-2,900
| -5% | -$51.9K |
|
74
Johnson Controls International
JCI
$68.9B
| $960K | 0.1% |
19,875
-410
| -2% | -$19.8K |
|
75
UBS Group
UBS
$126B
| $852K | 0.09% |
50,000
-50,000
| -50% | -$852K |
|